The emerging role of epidermal growth factor receptor (EGFR) inhibitors in first-line treatment for patients with advanced non-small cell lung cancer positive for EGFR mutations

Isamu Okamoto, Tetsuya Mitsudomi, Kazuhiko Nakagawa, Masahiro Fukuoka

Research output: Contribution to journalReview articlepeer-review

24 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The emerging role of epidermal growth factor receptor (EGFR) inhibitors in first-line treatment for patients with advanced non-small cell lung cancer positive for EGFR mutations'. Together they form a unique fingerprint.

Medicine & Life Sciences